Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

Ryan Cross

Senior Science Correspondent

We often imagine DNA as a stringlike molecule that’s easily scrunched up. But our six-foot-long genomes only fit inside our cells thanks to an intricate …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

All of 23andMe's independent board members resign over disagreements with CEO

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

Breaking down silos with a new quantitative approach to drug development

Ex­clu­sive: MIT spin­out launch­es with fo­cus on im­prov­ing DNA pay­loads for gene in­ser­tion

Senior Science Correspondent

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion